First drug for severe form of fatty liver disease approved

Credit: IndiaTimes- Published on March 15, 2024
Fatty liver disease, hepatic steatosis, NAFLD, NASH, liver cirrhosis, FDA approves Rezdiffra, Madrigal Pharmaceuticals, liver scarring, Nikolay Nikolov. Disease linked to obesity, high cholesterol, diabetes, alcohol abuse, with medication focusing on liver damage treatment.

You are here

Related news from verified sources

The FDA has approved Rezdiffra, the first medication for severe non-alcoholic fatty liver disease, showing improvement in liver scarring in NASH patients. NASH...
on March 15, 2024 • IndiaTimes

You might like